|As first author||6|
|As last author||78|
R Paul Ross(161)
Gerald F Fitzgerald(107)
Paul D. Cotter(38)
Timothy G. Dinan(34)
C Anthony Ryan(22)
P W O'Toole(17)
Paul W O’ Toole(16)
Eamonn M M Quigley(12)
A. A. Hennessy(10)
... and 153 others
These arethe11 unique sources for Catherine Stanton's 237 publications. A single publication may appear in multiple sources. Click on a name or publication count to see the publications for a particular source.
|Ireland -> Dublin City University||10|
|Ireland -> Dublin City University -> PubMed||10|
|Ireland -> Maynooth University||2|
|Ireland -> Maynooth University -> PubMed||1|
|Ireland -> National University of Ireland Galway||1|
|Ireland -> National University of Ireland Galway -> PubMed||1|
|Ireland -> Teagasc||186|
|Ireland -> Teagasc -> PubMed||154|
|Ireland -> University College Cork||54|
|Ireland -> University College Cork -> PubMed||23|
|Ireland -> University of Limerick||1|
An isolated Lactobacillus mucosae (DPC6426) strain deposited with the National Collection of Industrial and Marine Bacteria Limited (NCIMB) on 27th July 2012 under NCIMB Deposit Accession No. 42015.
Isolated bacteria are described that are characterised by being culturable, derived from a human neonatal gastrointestinal tract, and having the ability to produce gamma-aminobutyric acid. Also described is the use of the GABA-producing bacteria in the treatment or regulation of cardiovascular function, mood disturbance, anxiety, stress, pain and proliferative disorders.
The current invention provides use of a CLA -producing bacterium for the in viv o conversion in the gut of polyunsaturated fatty acids to CLA. The CLA- producing bacterium is selected from one or more of the group consisting of propionibacteria, lactobacilli, lactococci and streptococci, and bifidobacteria.
The present invention relates to Angiotensin-I-converting enzyme inhibitors and to methods of producing such inhibitors comprising culturing a Lactobacillus strain in the presence of milk proteins. Strains useful in the production of these inhibitors are disclosed. The invention also relates to functional foods comprising such inhibitors.
The present application is directed to a process for the production of trans-10, cis-12 conjugated linoleic acid in a transgenic microorganism comprising the steps of: (a) introducing into said microorganism at least one nucleic acid molecule encoding a trans-10, cis-12 conjugated linoleic acid isomerase, (b) culturing the transgenic microorganism obtained under (a), (c) inducing the production of trans-10, cis-12 conjugated linoleic acid by adding linoleic acid to the culture, (d) incubating the induced culture for at least 12 hours, and (e) isolating the conjugated linoleic acid from the culturemedia and/or transgenic microorganism.
The present invention relates generally to the field of health promoting agents, in particular antimicrobial agents and provides antimicrobial peptides and bacterial strains that provide the antimicrobial peptides. In one aspect, the invention provides a biologically pure culture of Lactobacillus acidophilus , strain DPC6026, a sample of which has been deposited at the National Collection of Industrial and Marine Bacteria, Aberdeen, Scotland on 18th November 2005 under the accession number NCIMB 41354, or a derivative or mutant thereof capable of producing from milk or a milk product, peptides having antimicrobial activity.
The invention provides a probiotic composition to alleviate Salmonella infection in farm animals. The composition may comprise at least one of Lactobacillus murinus, Lactobacillus pentosus, Lactobacillus salivarius sub-species salivarius, and Pediococcus pentosaceus. The composition maybe formulated as an animal feedstuff, or as a pharmaceutical composition.
Clicking through these tabs will give you a wealth of further insights into this expert through their commonly used topics, the evolution of their expertise, their collaborators and their publications.
Here is a quick breakdown of this expert's publication history
If this is the expert you have been looking for, simply click here to make contact.